D Weltin

490 total citations
25 papers, 432 citations indexed

About

D Weltin is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, D Weltin has authored 25 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in D Weltin's work include PARP inhibition in cancer therapy (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer therapeutics and mechanisms (3 papers). D Weltin is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer therapeutics and mechanisms (3 papers). D Weltin collaborates with scholars based in France, Croatia and Canada. D Weltin's co-authors include P. Dufour, Jean Marchal, Karine Aupeix, Philip Bischoff, Vincent Holl, David Coelho, Dominique Stéphan, José Enrique Mejía, Marielle Christ and Jean-Marie Freyssinet and has published in prestigious journals such as Journal of Neurochemistry, British Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

D Weltin

25 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Weltin France 11 255 124 91 59 52 25 432
Patricia Hentosh United States 14 351 1.4× 110 0.9× 92 1.0× 33 0.6× 38 0.7× 29 596
Jerome Hill United States 5 127 0.5× 93 0.8× 118 1.3× 87 1.5× 22 0.4× 8 381
Amy C. Munthe‐Kaas Norway 11 190 0.7× 104 0.8× 80 0.9× 138 2.3× 20 0.4× 18 595
Hong Xin United States 12 224 0.9× 92 0.7× 105 1.2× 51 0.9× 22 0.4× 17 496
Szu-Yu Kuo Taiwan 10 228 0.9× 48 0.4× 54 0.6× 80 1.4× 20 0.4× 15 497
L.W. Estes United States 7 219 0.9× 265 2.1× 109 1.2× 38 0.6× 44 0.8× 9 563
Jelena Zarić Switzerland 8 162 0.6× 29 0.2× 64 0.7× 33 0.6× 20 0.4× 15 377
J. Klicius United States 7 237 0.9× 36 0.3× 66 0.7× 71 1.2× 72 1.4× 10 476
Lian Wang China 10 376 1.5× 119 1.0× 42 0.5× 38 0.6× 37 0.7× 33 668
Valdemar Hial Brazil 10 180 0.7× 34 0.3× 102 1.1× 30 0.5× 20 0.4× 18 494

Countries citing papers authored by D Weltin

Since Specialization
Citations

This map shows the geographic impact of D Weltin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Weltin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Weltin more than expected).

Fields of papers citing papers by D Weltin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Weltin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Weltin. The network helps show where D Weltin may publish in the future.

Co-authorship network of co-authors of D Weltin

This figure shows the co-authorship network connecting the top 25 collaborators of D Weltin. A scholar is included among the top collaborators of D Weltin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Weltin. D Weltin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Neuville, Agnès, et al.. (2005). Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in prehypertensive spontaneously hypertensive rats. Journal of Hypertension. 23(8). 1559–1564. 7 indexed citations
3.
Zaric, Violeta, D Weltin, Patrick Erbacher, et al.. (2004). Effective polyethylenimine‐mediated gene transfer into human endothelial cells. The Journal of Gene Medicine. 6(2). 176–184. 63 indexed citations
4.
Weltin, D, et al.. (2003). Cholestatic hepatitis caused by fluindione.. PubMed. 57(6). 589–90. 2 indexed citations
5.
Hyun, Jin Won, Vincent Holl, D Weltin, et al.. (2002). Effects of combinations of 7beta-hydroxycholesterol and anticancer drugs or ionizing radiation on the proliferation of cultured tumor cells.. PubMed. 22(2A). 943–8. 16 indexed citations
6.
Guggino, Sandra E., et al.. (2002). [Anti-angiogenesis effects of aldosterone antagonist diuretics].. PubMed. 95(7-8). 727–31. 2 indexed citations
7.
Holl, Vincent, David Coelho, D Weltin, et al.. (2001). Induction de l'apoptose dans les lymphocytes spléniques de souris par un faisceau d'ions carbone. Canadian Journal of Physiology and Pharmacology. 79(2). 109–113. 1 indexed citations
8.
Coelho, David, Vincent Holl, D Weltin, et al.. (2000). Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells. British Journal of Cancer. 83(5). 642–649. 38 indexed citations
9.
Holl, Vincent, David Coelho, D Weltin, et al.. (2000). Ex VivoDetermination of the Effect of Whole-Body Exposure to Fast Neutrons on Murine Spleen Cell Viability and Apoptosis. Radiation Research. 154(3). 301–306. 8 indexed citations
10.
Bischoff, Pierre, Vincent Holl, David Coelho, et al.. (2000). Apoptosis at the Interface of Immunosuppressive and Anticancer Activities: The Examples of Two Classes of Chemical Inducers, Oxysterols and Alkylating Agents. Current Medicinal Chemistry. 7(7). 693–713. 25 indexed citations
11.
Holl, Vincent, et al.. (2000). Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.. PubMed. 20(5A). 3233–41. 24 indexed citations
12.
Holl, Vincent, Pierre M. J. Jung, D Weltin, et al.. (2000). Evaluation of the antitumor activity of 1-(3-C-ethynyl-beta-D-ribofuranosyl) (PJ272), a recent ribonucleoside analogue.. PubMed. 20(3A). 1739–42. 1 indexed citations
13.
Weltin, D, et al.. (2000). Gene therapy for coronary disease.. PubMed. 61(1). 85–90. 2 indexed citations
14.
Weltin, D, et al.. (1998). Modulation de l'apoptose radioinduite par Ac-DEVD-CHO, un inhibiteur de protéases “ice-like". Journal de Chimie Physique. 95(4). 898–899. 1 indexed citations
15.
Weltin, D, et al.. (1997). Cytotoxic properties of a phosphoglycoconjugated derivative of 7 beta-hydroxycholesterol upon normal and tumor cells in culture.. PubMed. 17(4A). 2621–6. 9 indexed citations
16.
Weltin, D, et al.. (1996). N-acetylcysteine protects lymphocytes from nitrogen mustard-induced apoptosis. Biochemical Pharmacology. 51(9). 1123–1129. 26 indexed citations
17.
Weltin, D, V. Picard, Karine Aupeix, et al.. (1995). Immunosuppressive activities of 6(5h)-phenanthridinone, a new poly(adp-ribose)polymerase inhibitor. International Journal of Immunopharmacology. 17(4). 265–271. 45 indexed citations
18.
Aupeix, Karine, D Weltin, José Enrique Mejía, et al.. (1995). Oxysterol-induced Apoptosis in Human Monocytic Cell Lines. Immunobiology. 194(4-5). 415–428. 97 indexed citations
19.
Weltin, D, et al.. (1994). Age‐Associated Changes of Rat Brain Neuronal and Astroglial Poly(ADP‐Ribose) Polymerase Activity. Journal of Neurochemistry. 62(2). 502–506. 12 indexed citations
20.
Masmoudi, Ahmed, et al.. (1993). Association of mitochondrial ADP-ribosyl transferase activity with the DNA-protein complex.. PubMed. 29(1). 77–83. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026